Three new biotech products recently hit the market that have the potential to steer the GMO debate in more productive directions.
Whoever thought that France and organic agriculture would be world leaders for the introduction of GE (genetically engineered) wheat? A stretch? Not as much as it might seem. What follows is the story of how plant breeders engineered a unlikely new crop through a series of sophisticated “conventional” techniques to move a use gene from a wild plant into wheat, despite the fact that the two plants could not be naturally crossbred.
Alison Van Eenennaam explains why the FDA’s proposed regulations on biotech breeding make no sense.